Sabyasachi Sen (S Sen)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 13

Top Topics

Diabetic Nephropathy

Cardiovascular Disease

Positive Airway Pressure

Top Venues

Metabolic syndrome and related disorders

Stem cell research & therapy

Cardiovascular diabetology

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Seshagiri Rao Nandula, Eric S Nylen, Sabyasachi Sen
Novel Therapeutics in Nonalcoholic Fatty Liver Disease: A Focus on Adult Stem Cells. Metabolic syndrome and related disorders 21 (2) (2023)
Seshagiri Rao Nandula, Eric S Nylen, Sabyasachi Sen
Novel Therapeutics in Nonalcoholic Fatty Liver Disease: A Focus on Adult Stem Cells. Metabolic syndrome and related disorders (2023)
Seshagiri Rao Nandula, Eric S Nylen, Sabyasachi Sen
Novel Therapeutics in Nonalcoholic Fatty Liver Disease: A Focus on Adult Stem Cells. Metabolic syndrome and related disorders 21 (2) (2023)
Resmi Premji, Eric S Nylen, Nejat Naser, Shruti Gandhi, Kenneth D Burman, Sabyasachi Sen
Lipid Profile Changes Associated with SGLT-2 Inhibitors and GLP-1 Agonists in Diabetes and Metabolic Syndrome. Metabolic syndrome and related disorders 20 (6) (2022)
Adrian Farid Elzarki, Seshagiri Rao Nandula, Hassan Awal, Gary L Simon, Sabyasachi Sen
Cardiovascular disease (CVD) risk assessment of HIV medication regimens using hematopoietic CD34+ progenitor cells. Stem cell research & therapy 13 (1) (2022)
Seshagiri Rao Nandula, Nabanita Kundu, Hassan B Awal, Beda Brichacek, Mona Fakhri, Nikhila Aimalla, Adrian Elzarki, Richard L Amdur, Sabyasachi Sen
Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes. Cardiovascular diabetology 20 (1) (2021)
Hassan B Awal, Seshagiri Rao Nandula, Cleyton C Domingues, Fiona J Dore, Nabanita Kundu, Beda Brichacek, Mona Fakhri, Adrian Elzarki, Neeki Ahmadi, Shauna Safai, Magan Fosso, Richard L Amdur, Sabyasachi Sen
Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial. Cardiovascular diabetology 19 (1) (2020)
Nabanita Kundu, Cleyton C Domingues, Jay Patel, Mohammed Aljishi, Neeki Ahmadi, Mona Fakhri, Allison C Sylvetsky, Sabyasachi Sen
Sucralose promotes accumulation of reactive oxygen species (ROS) and adipogenesis in mesenchymal stromal cells. Stem cell research & therapy 11 (1) (2020)
Sabyasachi Sen
Adult Stem Cells: Beyond Regenerative Tool, More as a Bio-Marker in Obesity and Diabetes. Diabetes & metabolism journal 43 (6) (2020)
Cleyton C Domingues, Nabanita Kundu, Yana Kropotova, Neeki Ahmadi, Sabyasachi Sen
Antioxidant-upregulated mesenchymal stem cells reduce inflammation and improve fatty liver disease in diet-induced obesity. Stem cell research & therapy 10 (1) (2019)
Cleyton C Domingues, Fiona J Dore, Alexander Cho, Neeki Ahmadi, Yana Kropotova, Nabanita Kundu, Naji Younes, Vivek Jain, Sabyasachi Sen
Reassessing the effects of continuous positive airway pressure (CPAP) on arterial stiffness and peripheral blood derived CD34+ progenitor cells in subjects with sleep apnea. Stem cell research & therapy 10 (1) (2019)
Jaideep Banerjee, J Ghose, M Sinha, Sabyasachi Sen
Redox Control of Vascular Biology. Oxidative medicine and cellular longevity 2019 (2019)
Fiona J Dore, Cleyton C Domingues, Neeki Ahmadi, Nabanita Kundu, Yana Kropotova, Sara Houston, Carol Rouphael, Aytan Mammadova, Linda Witkin, Anamil Khiyami, Richard L Amdur, Sabyasachi Sen
The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial. Cardiovascular diabetology 17 (1) (2018)